Putnam Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-134,954
Closed -$11.7M 1146
2023
Q2
$11.7M Sell
134,954
-76
-0.1% -$6.59K 0.02% 279
2023
Q1
$13.1M Buy
+135,030
New +$13.1M 0.02% 268
2020
Q3
Sell
-1,697
Closed -$210K 837
2020
Q2
$210K Buy
+1,697
New +$210K ﹤0.01% 856
2019
Q2
Sell
-909,552
Closed -$80.8M 892
2019
Q1
$80.8M Sell
909,552
-252,267
-22% -$22.4M 0.19% 131
2018
Q4
$98.9M Buy
1,161,819
+389,551
+50% +$33.2M 0.26% 115
2018
Q3
$74.9M Buy
772,268
+258,110
+50% +$25M 0.16% 143
2018
Q2
$48.4M Buy
+514,158
New +$48.4M 0.11% 171
2017
Q2
Sell
-366,054
Closed -$32.1M 1127
2017
Q1
$32.1M Sell
366,054
-352,829
-49% -$31M 0.08% 212
2016
Q4
$59.6M Buy
718,883
+93,762
+15% +$7.77M 0.14% 156
2016
Q3
$57.8M Buy
625,121
+179,447
+40% +$16.6M 0.14% 164
2016
Q2
$34.7M Sell
445,674
-599
-0.1% -$46.6K 0.08% 212
2016
Q1
$36.8M Buy
446,273
+42,210
+10% +$3.48M 0.09% 206
2015
Q4
$42.3M Sell
404,063
-312
-0.1% -$32.7K 0.1% 199
2015
Q3
$42.6M Buy
404,375
+1,483
+0.4% +$156K 0.1% 204
2015
Q2
$55.1M Buy
402,892
+600
+0.1% +$82.1K 0.11% 193
2015
Q1
$50.1M Sell
402,292
-64,905
-14% -$8.09M 0.1% 210
2014
Q4
$42.2M Sell
467,197
-136,064
-23% -$12.3M 0.09% 228
2014
Q3
$43.5M Buy
603,261
+60,554
+11% +$4.37M 0.09% 201
2014
Q2
$33.8M Buy
542,707
+184,146
+51% +$11.5M 0.07% 251
2014
Q1
$24.5M Sell
358,561
-98,836
-22% -$6.74M 0.06% 293
2013
Q4
$32.1M Sell
457,397
-75,625
-14% -$5.31M 0.08% 258
2013
Q3
$38.5M Sell
533,022
-90,024
-14% -$6.5M 0.1% 211
2013
Q2
$34.8M Buy
+623,046
New +$34.8M 0.1% 217